Draft, not yet released. In stewardship review. Not indexed until the first approved release.
- அறிக்கைகள்
- அதிவேகத் தொழில்நுட்பம்
- Baseline Edition 2026
Exponential Technology Report 2026: Genomics and Gene Editing
The first annual edition of the genomics report. It fixes the 2026 reference state of genomics and gene editing as infrastructure, and the model, voice and positions, against which the 2027 edition will be read.
- Editor
- Saeed Valadbaygi
- Desk
- GCRI Systems Evidence
- Publisher of record
- GCRI for the Nexus Consortium
- Collection
- Reports Collection 2026
- Evidence close
- 30 September 2026
- நிலை
- Draft in stewardship review; not yet released
01 · Status
Status and boundaries.
This edition governs nothing and certifies nothing. It records where the global evidence stood at the 2026 baseline. Every value resolves to its source or to its stated method; where neither exists, the edition says so instead of filling the gap.
- Publication ID
- NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE-v1.0.0
- Series alias
- NR-XTC-XT-05-2026-BL
- Identifier status
- Series alias and evidence cut are provisional until the owner confirms them. No UNI is minted.
- Family · class
- Exponential Technology Report XT-05 · Baseline Edition (inaugural annual)
- Lifecycle state
- ◌ DRAFT, review copy before stewardship review
- Publication date
- October 2026
- Evidence close
- 30 September 2026 · cut DC-XTECH-GENOMICS-GLOBAL-2026-B0
- Reproducibility
- sourced values cited; analytical values reproducible from stated parameters
- Access class
- PUBLIC-SAFE DERIVATIVE
- மதிப்பாய்வு
- five passes scheduled before release (in Annex C)
- Designed for
- strategic planning · technology-risk screening · readiness discussion · research · public communication
- Not for
- government assessment · official warning · rating · certification · investment advice · underwriting · procurement · operational authorisation
- பதிவேடு
- record NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE · current-version pointer at release
- திருத்தங்கள்
- registry correction pathway · history in Annex C
- Genomics use
- disclosed in Annex C
- Next edition
- NR-XTECH-GENOMICS-GLOBAL-2027-v1.0.0 · 2027 annual
- உரிமம்
- text CC BY 4.0 · data on the terms of each source
- Desk identifier
- NR-GCRI-XT-05-2026-BASELINE-v1.0.0
- Collection
- NR-COL-2026-BASELINE
02 · Key messages
What the edition finds.
Five of the questions the edition answers, each with its status. The executive summary has all of them, with their sources.
In two phase 3 studies most evaluable patients met the primary end point at short follow-up.
Do editing therapies work?Reported
The FDA approved Casgevy on 8 December 2023 for patients 12 and older.
Is the approval real?Reported
One infant received a patient-specific base editor in 2025; one case is not a trend.
Can a therapy be made for one patient?Reported
No. A 2023 death after high-dose viral vector therapy and a 2025 liver event show open risks.
Is the safety record settled?Reported
A complete genome of 3.055 billion base pairs and genome releases of 245,388 and 490,640 people.
How large are the data resources?Reported
03 · Contents
Eight chapters and three annexes.
- ·
The edition on a few pages: the abstract, the key messages, the headline finding and what each steward reads in it.
- 1
Chapter 1. Genomics is data infrastructure and a therapeutic frontier
Part I describes systems and their couplings.
- 2
Twelve findings carry the genomics baseline.
- 3
- 4
Chapter 4. Risks and capability
Four genomics risk objects open the portfolio.
- 5
Chapter 5. Individualised editing outpaces delivery systems
A conditional statement under stated assumptions, never a prediction.
- 6
Chapter 6. Readings from the other desks
The genomics baseline is read through each steward’s lens, then once as a whole.
- 7
Eight bounded questions open the 2027 genomics agenda.
- 8
One section per system: its state at evidence close, its exposures and what the operational series will watch.
- A
How the edition was made: methods, the model card, the evidence cut and its age, the acceptance record and the glossary.
- B
The indicator set with its sources, the source registers, the licences of every kind of material and the formats of the edition.
- C
Annex C. References and record
Every source the edition rests on, the publication record, the corrections log and the open record.
List of figures (4)
List of tables (45)
- 1.1Coupling matrix: from the row system to the column system
- 3.1Each domain read in words, not scored
- 3.2Sectors: baseline evidence and the exposure to watch
- 4.1Capabilities on the ladder of evidence: listed, exists, demonstrated, tested
- 6.1The quarterly rhythm every edition follows
- 6.2Who contributes what each quarter
- 6.32027 genomics readiness pack
- 6.4Standards and regulatory watch
- 6.5Peer-reviewed science and preprints
- 6.6Clinical evidence and safety
- 6.7Standards, policy and governance
- 6.8Supply, market and data overviews
- 7.1Objects proposed for the first operational quarter
- 7.2Universe 2027: evidence pack for the genomics candidate mission
- 7.3Handoffs and routing
- 7.4Routing rules by publication class
- 7.5Feeds watched from 2027
- 7.6Signals at baseline
- 8.1State at baseline
- 8.2State at baseline
- 8.3State at baseline
- 8.4State at baseline
- 8.5State at baseline
- A.1முறைகள்
- A.2Coupling strength scale (matrix and model card)
- A.3Status grammar
- A.4From the baseline cut to the federation cut
- A.5Evidence age and coverage
- A.6Coverage by system at baseline
- A.7Designed empty states: what is not bound, what would fill it and why
- A.8Quality dimensions at baseline
- A.9Publication acceptance record
- A.10The status every value carries
- A.11Series terms
- A.12Abbreviations used in this edition
- A.13Technical annex
- B.1Global baseline indicator set
- B.2Global baseline indicator set
- B.3Global source register
- B.4Regional reading, genomics across ten clusters
- B.5How countries appear in the genomics edition
- B.6National Baseline Editions in the 2026 programme
- B.7Licences of each kind of material
- B.8This edition in every format
- C.1Release path for this version
04 · GCRI reading
How GCRI reads this edition.
The evidence supports reading genomics as data infrastructure and as a therapeutic technology. Results are strong for one therapy family and for reference data, and the physical, cost and supply layers are thinly measured. Evidence is strongest for single peer-reviewed results, and weakest for energy, cost and treatment counts.
HLT-001 · DAT-006 · GOV-011 · SYS-012
05 · Publication record
Version, dates and contributors.
The identity of this edition as its title pages record it. A review copy has no DOI; the DOI is issued at deposit.
- Publication ID
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE-v1.0.0- பதிப்பு
- 1.0.0, review copy
- Edition date
- Evidence close
- நிலை
- Draft under stewardship review; not yet released
- Editor
- Saeed Valadbaygi
- Publisher of record
- Global Centre for Risk and Innovation (GCRI)
- Licence of the text
- CC BY 4.0
- DOI
- Issued at deposit, on release
- Previous edition
- none: first edition of the series
- Next edition
- NR-XTECH-GENOMICS-GLOBAL-2027-v1.0.0
Contributors
| பங்கு | Contribution | By |
|---|---|---|
| Conceptualisation | Series architecture and the genomics model | S. Valadbaygi (ed.) |
| Methodology | Baseline method, dependency scoring and status grammar | Reports editorial team, GCRI |
| Investigation · data curation | Source review of genomics releases, statistics and the peer-reviewed literature to evidence close | Reports editorial team, GCRI |
| Writing, original draft | All chapters; genomics-assisted drafting, disclosed below | Editor · editorial team |
| Writing, review and editing | Five review passes before release | Steward reviewers (scheduled) |
| Visualisation | Pages, figures and tables in the Nexus design standard | Reports editorial team, GCRI |
| Supervision | Edition governance, registry record and deposit | S. Valadbaygi (ed.) |
Review before release
| Pass | வரம்பு | By | நிலை |
|---|---|---|---|
| 1 | Scientific and technical | GCRI · key T | Scheduled |
| 2 | Reproducibility of analytical values | GCRI · key T | Scheduled |
| 3 | Public meaning and claims | The Global Risks Forum (GRF) · key M | Scheduled |
| 4 | Finance-readiness boundary | The Global Risks Alliance (GRA) · key F | Scheduled |
| 5 | Regional context, safeguards and dual use | Regional consortia · key N | Scheduled |
Genomics assistance was used for drafting, consistency checks and page composition. Every number, citation and status label was checked against its source by the editorial team before freeze. No genomics system is recorded as an author or a reviewer, and no genomics output is printed as fact without a source.
06 · Downloads
Read it in print, take the data.
Draft, not yet releasedReview copies of a draft in stewardship review. The released edition carries its DOI and replaces them.
Print
PDF, A4
The designed print edition, A4: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.
PDF113 pages1.0 MBTagged, with bookmarks
SHA-256
7276b0b0c2919661f94a296cdb60a579d1cb5466d3fab3011f46a9d5e81e42d6PDF, US Letter
The designed print edition, US Letter: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.
PDF123 pages1.0 MBTagged, with bookmarks
SHA-256
da38a3579fdd5a3ac5c84f44a22853584be7e987208657578ede146f7b88fd58
Web edition
Complete edition, one page
Every chapter and annex at one address, with running heads when printed from the browser
HTML
Edition home
Key messages, contents, citation and the readings of each desk
HTML
Data bundle
Indicators, CSV
16 indicators with unit, year, status and source
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE-indicators.csv1 KB
SHA-256
f1c3fc5ae9f6823c263bb4a464c29a9516551ab806ef2a07fc3e737d1cd85a8dIndicators, JSON
The same indicators with the edition’s identity and licence
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE-indicators.json2 KB
SHA-256
c54a918f9a805a488a8931ec6c1a235eb273361704df0909aae23d83048aa489Findings, CSV
12 findings with status, evidence-quality level and references
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE-findings.csv3 KB
SHA-256
0cb51833261dd188ca2af8a452aa38bbf651743f01a98776ff39430d07bcb97f
Citation files
Citation, BibTeX
For LaTeX and reference managers
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE.bib1 KB
SHA-256
a09328c6428b83ba58eba3284cc50b50417b9fccd1c4d685a53746ed430fac83Citation, RIS
For Zotero, EndNote and Mendeley
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE.ris1 KB
SHA-256
95ff0d92b09d48fa348d982302647ab3ab0709cf5aaccccde30e735cade45a16Citation, CITATION.cff
Citation File Format 1.2.0, for GitHub, Zenodo and software catalogues
NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE.cff1 KB
SHA-256
16aeb56c4b5eb0bfe8917c7848aec9209776f6cf7708280877069c0cfe0ef1f2
Check a file with its SHA-256: shasum -a 256 <file> (macOS, Linux) or Get-FileHash <file> (Windows). Text, tables and figures by Nexus: CC BY 4.0; each source keeps its own licence.
07 · Cite
Cite this report.
Standards applied to NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE
Cite as
S. Valadbaygi (ed.), Exponential Technology Report 2026: Genomics and Gene Editing. Reports, Baseline Edition 2026. The Global Centre for Risk and Innovation (GCRI) for the Nexus Consortium, Toronto, 2026. NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE. DOI at deposit.
Applied
NS-1 catalogue identity (a UNI is allocated at deposit and resolves to this record), NS-2 citation and attribution, NS-3b dataset metadata, NS-5 figures and maps, NS-12 software and AI disclosure.
கண்காணிப்பு
Corrections are new versions with a published notice; the earlier version stays resolvable.
An attestation is evidence, not a certificate. Nexus Standards parts are preparatory working drafts (2026).
APA 7
Valadbaygi, S. (Ed.). (2026). Exponential Technology Report 2026: Genomics and Gene Editing (Baseline Edition 2026, Report No. NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI). https://therisk.global/nexus-reports/editions/xt-05/
Chicago
Valadbaygi, Saeed, ed. Exponential Technology Report 2026: Genomics and Gene Editing. Baseline Edition 2026. Nexus Reports NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE. Draft under review. Toronto: The Global Centre for Risk and Innovation (GCRI), 2026. https://therisk.global/nexus-reports/editions/xt-05/.
BibTeX
@techreport{NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE,
author = {{GCRI Systems Evidence}},
editor = {Valadbaygi, Saeed},
title = {{Exponential Technology Report 2026: Genomics and Gene Editing}},
institution = {The Global Centre for Risk and Innovation (GCRI)},
address = {Toronto},
year = {2026},
type = {Nexus Reports, Baseline Edition 2026},
number = {NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE},
note = {Draft under stewardship review; not yet released. DOI assigned at deposit},
url = {https://therisk.global/nexus-reports/editions/xt-05/}
}RIS
TY - RPRT AU - GCRI Systems Evidence ED - Valadbaygi, Saeed TI - Exponential Technology Report 2026: Genomics and Gene Editing T3 - Nexus Reports ET - Baseline Edition 2026 PY - 2026 PB - The Global Centre for Risk and Innovation (GCRI) CY - Toronto SN - NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE UR - https://therisk.global/nexus-reports/editions/xt-05/ N1 - Draft under stewardship review; not yet released. DOI assigned at deposit. LA - en ER -
NR-CIT-1 (house style)
S. Valadbaygi (ed.), Exponential Technology Report 2026: Genomics and Gene Editing. Nexus Reports, Baseline Edition 2026. The Global Centre for Risk and Innovation (GCRI) for the Nexus Consortium, Toronto, 2026. NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE. DOI at deposit.
08 · Related
In the same series, and across the Consortium.
- அறிக்கைகள்XT-01
அதிவேகத் தொழில்நுட்பம்
AI and Agentic Systems 2026
Baseline Edition 2026NR-XTECH-AI-GLOBAL-2026-BASELINEGCRI for the Nexus Consortium - அறிக்கைகள்XT-02
அதிவேகத் தொழில்நுட்பம்
Quantum Technologies 2026
Baseline Edition 2026NR-XTECH-QUANTUM-GLOBAL-2026-BASELINEGCRI for the Nexus Consortium - அறிக்கைகள்XT-03
அதிவேகத் தொழில்நுட்பம்
Robotics and Autonomous Systems 2026
Baseline Edition 2026NR-XTECH-ROBOTICS-GLOBAL-2026-BASELINEGCRI for the Nexus Consortium - அறிக்கைகள்XT-04
அதிவேகத் தொழில்நுட்பம்
Synthetic Biology and Bioengineering 2026
Baseline Edition 2026NR-XTECH-SYNBIO-GLOBAL-2026-BASELINEGCRI for the Nexus Consortium - அறிக்கைகள்XT-06
அதிவேகத் தொழில்நுட்பம்
Advanced Semiconductors and AI Compute 2026
Baseline Edition 2026NR-XTECH-SEMICONDUCTORS-GLOBAL-2026-BASELINEGCRI for the Nexus Consortium - அறிக்கைகள்XT-07
அதிவேகத் தொழில்நுட்பம்
HPC and Advanced Computing 2026
Baseline Edition 2026NR-XTECH-HPC-GLOBAL-2026-BASELINEGCRI for the Nexus Consortium
Send evidence or a correction on Genomics and Gene Editing.
Reports is the Consortium’s quarterly publication, written by six desks. This page sits with the GCRI Systems Evidence desk. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work. Sent to the wrong desk, it is forwarded, not refused.
- EmailGateway GW-GCRISend it from this pageEvidence, a correction, a case, a method, a review, a translation or profile input. It arrives tagged with this page, so the editor who owns it receives it.
- ZenodoOpen depositDeposit it and submit to the communityPublish your own record on Zenodo with your ORCID iD, then submit it to the Reports community there. Curators review it; the DOI stays yours.
- அறிக்கைகள்GCRIஉங்களிடம் உள்ளதை எந்தப் பிரிவு ஏற்கிறது என்பதைக் காண்கவழித்தட அட்டவணை பங்களிப்புப் பக்கத்தைத் திறக்கிறது: உங்களிடம் உள்ளது, அதை ஏற்கும் பிரிவு, ஒவ்வொரு பங்களிப்பும் எவ்வாறு மதிப்பாய்வு செய்யப்பட்டு அங்கீகரிக்கப்படுகிறது, மற்றும் உரிமம்.
தனிப்பட்ட தரவு, உணர்திறன் வாய்ந்த உள்கட்டமைப்பு விவரங்கள் அல்லது பகிர உங்களுக்கு உரிமை இல்லாத எதையும் ஒருபோதும் அனுப்ப வேண்டாம். ஒரு பங்களிப்பு பயன்படுத்தப்படும் முன் மதிப்பாய்வு செய்யப்படுகிறது; அதை அனுப்புவது எந்த ஆசிரியர் உரிமையையோ பதிப்பு உரிமையையோ வழங்காது, நிதியுதவி ஒருபோதும் ஒரு கண்டுபிடிப்பை விலைக்கு வாங்காது.
Reports · GCRI
Bring evidence to the next edition.
Every quarter closes on a sealed evidence cut. A correction, a source or a method received before the cut is reviewed for that edition.
- NR-XTECH-GENOMICS-GLOBAL-2026-BASELINE
- CC BY 4.0
- Evidence close 30 September 2026
CC BY 4.0 Free to read. Text and figures: CC BY 4.0. Data: CC0 1.0. Authors keep copyright. Published by GCRI Canada.
What you can do from this page.
- ReaderNew to the reports? A short guide to reading an edition.Start here
- ContributorYour contributions to this edition and the reviews open on it are listed below the edition.Contribute
- ReviewerReview for this desk; verified reviews are credited.Become a reviewer
- Editor, steward or boardQueues, decisions and production are in the workspace.My workspace
This edition
Contributions and reviews on XT-05
- Open contributions to this edition
- 0
- Reviews open on this edition
- 0
Open your account on this site to see your own contributions to this edition and any review invited from you.
